共 133 条
[1]
Benjamin EJ(2019)Heart Disease and Stroke Statistics-2019 Update: a report from the American Heart Association Circulation 139 e56-e528
[2]
Muntner P(2008)Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study) Am J Cardiol 101 1016-1022
[3]
Alonso A(2006)Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 251-259
[4]
Loehr LR(2013)The emerging epidemic of heart failure with preserved ejection fraction Curr Heart Fail Rep 10 401-410
[5]
Rosamond WD(2018)Trends in hospitalizations and survival of acute decompensated heart failure in four us communities (2005–2014): ARIC Study Community Surveillance Circulation 138 12-24
[6]
Chang PP(2005)Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms J Card Fail 11 177-187
[7]
Folsom AR(2016)Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap Circulation 134 73-90
[8]
Chambless LE(2011)Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial Circ Heart Fail 4 324-331
[9]
Owan TE(2020)Obese-inflammatory phenotypes in heart failure with preserved ejection fraction Circ Heart Fail 13 e006414-555
[10]
Hodge DO(2020)Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning Heart 106 342-1103